India to Japan: Pravastatin Export Trade Route

The India to Japan Pravastatin corridor is one of India's established pharmaceutical export routes, with 41 shipments documented worth a combined $4.3M USD. The route is dominated by MEDREICH LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's pravastatin manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $105.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with pravastatin's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 24.5%, placing it at rank #20 among India's top pravastatin export destinations globally.

On the import side, key buyers of Indian pravastatin in Japan include MEIJI SEIKA PHARMATECH CO., LTD, MEIJI SEIKA PHARMATECH CO LIMITED, MEIJI SEIKA PHARMATECH CO LTD and 1 others. MEIJI SEIKA PHARMATECH CO., LTD is the single largest importer with 22 shipments valued at $2.6M USD.

India's pravastatin exports to Japan are driven primarily by a handful of large-scale manufacturers. MEDREICH LIMITED with 41 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Japan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MEDREICH LIMITED — together account for 100% of total trade value on this route. The average shipment value of $105.5K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as pravastatin sodium 10mg tablets po no.m and pravastatin 10mgtabs 40000s-nn-nissin/ja , suggesting that buyers in Japan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MEIJI SEIKA PHARMATECH CO., LTD is the largest importer with 22 shipments worth $2.6M USD — representing 60% of all pravastatin imports from India on this route.